Indication

Meningococcemia

Meningococcemia is a life-threatening, acute bloodstream infection caused by the bacterium *Neisseria meningitidis*. Read more about Meningococcemia

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Meningococcemia therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Meningococcemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Meningococcemia.

Meningococcemia is a life-threatening, acute bloodstream infection caused by the bacterium *Neisseria meningitidis*.

The systemic dissemination predominantly impacts the vascular endothelium and hematologic system, commonly presenting in infants, adolescents, and immunocompromised individuals.

Pathophysiologically, high bacterial loads and endotoxin release induce widespread endothelial injury, hypercoagulability, and severe capillary leak.

It clinically manifests as sudden-onset fever, rapid hemodynamic collapse, and a characteristic non-blanching petechial or purpuric rash that can rapidly progress to purpura fulminans, disseminated intravascular coagulation, and multiorgan failure.

Personalize your experience

Follow Meningococcemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it